-+ 0.00%
-+ 0.00%
-+ 0.00%

Sunshine Nuohe announced that the company and its wholly-owned subsidiary Jiangsu Nuohe Billituo New Pharmaceutical Research & Development Co., Ltd. received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration. The BTP0427 compound sustained-release capsule clinical trial application was approved for the treatment of chronic heart failure with reduced ejection fraction.

Zhitongcaijing·09/16/2026 09:33:03
Listen to the news
Sunshine Nuohe announced that the company and its wholly-owned subsidiary Jiangsu Nuohe Billituo New Pharmaceutical Research & Development Co., Ltd. received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration. The BTP0427 compound sustained-release capsule clinical trial application was approved for the treatment of chronic heart failure with reduced ejection fraction.